Mathematical model suggests current CAR-macrophage dosage is efficient to low pre-infusion tumour burden but refractory to high tumour burden

Related articles

1. Quantitative Insights into CAR-T Cell Therapy: The Interplay of Dose, Dosing Regimen, Proliferation and Tumour Elimination

   This article has 3 authors:

   1. Shilian Xu
   2. Maoxuan Liu
   3. Jiaru Yang

2. Hyper-migratory CAR T cells alleviate ovarian cancer metastatic burden and improve prognosis

   This article has 6 authors:

   1. Praful R. Nair
   2. Eban Hanna
   3. Saurabh Joshi
   4. Victoria Duarte-Alvarado
   5. Challice L. Bonifant
   6. Denis Wirtz

3. Focal adhesion pathway inhibition is the central axis of macrophage phenotypic responses to monoclonal antibody therapy in aggressive lymphoma via high-throughput screening and high-content imaging

   This article has 15 authors:

   1. Stuart James Blakemore
   2. Peter Zentis
   3. Linda Mueller
   4. Reinhild Brinker
   5. Michael Michalik
   6. Christian Juengst
   7. Anna Beielstein
   8. Jing Zhang
   9. Rene Neuhaus
   10. Alexandra Florin
   11. Michael Hallek
   12. Joern Meinel
   13. Reinhard Buettner
   14. Astrid Schauss
   15. Christian Pallasch